Manitex Capital Inc. is a Canada-based company that specializes in acquiring interests in companies and participates in increasing shareholder value in these businesses. The Company operates through three segments: diversified investments (investment), biotechnology (biotech) and a pharmaceutical business (pharma). The investment segment holds interests in companies in the life science industry and also invests in marketable securities. Through its subsidiary, ANRis Pharmaceuticals Inc. (ANRis), (the biotechnology segment), the Company specializes in development of the delivery of nucleic acids for therapeutic purposes. Through its subsidiary, Valeo Pharma Inc. (Valeo), (the pharmaceutical segment), the Company acquires and markets specialty pharmaceutical products and also markets and distributes third-party pharmaceutical products. VPI Pharmaceuticals Inc. is the subsidiary of the Valeo.